nfectIons have been and will always serve as one of the main sources of pathologies. Although the vast majority involve the respiratory, gastrointestinal, and genitourinary organ systems, the vertebral bodies are not excluded from involvement and account for 2%-7% of musculoskeletal infections. 5 Vertebral osteomyelitis is not an infrequent pathology and has been reported to occur at approximately 0.2-2 cases per 100,000 annually.
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I nfectIons have been and will always serve as one of the main sources of pathologies. Although the vast majority involve the respiratory, gastrointestinal, and genitourinary organ systems, the vertebral bodies are not excluded from involvement and account for 2%-7% of musculoskeletal infections. 5 Vertebral osteomyelitis is not an infrequent pathology and has been reported to occur at approximately 0.2-2 cases per 100,000 annually. 5, 6 Associated inflammatory septic discitis is extremely rare, seen in 1 of 250,000 and 2%-4% of all osteomyelitis infections. 25 In the majority of cases, an insidious onset of back or neck pain is reported, often taking months to years to develop. 5, 6 Most back pain stems from degenerative processes; however, a population-based study by Carey et al. indicated that up to 7.6% of acute back pain and 3.9% of chronic pain stems from vertebral osteomyelitis. 3 A variety of associated symptoms exist including limited range of motion, discomfort, lethargy, confusion, anorexia, nausea and vomiting, and weight loss. Surprisingly, fewer than 20% of patients present with fever. Neurological symptoms are rare and are typically only seen when associated with mass effect-for example, in the presence of an abscess. 5, 6, 22 A review by Tali found the prevalence of spinal infections to be twice as high in males as females, 23 although more recent reports have not shown any major difference between sexes. Numerous risk factors are associated with spinal infections, the most common involving direct exposure of the vertebral bodies to pathogens introduced during prior surgery and trauma. Other risk factors include diabetes mellitus, malnutrition, substance abuse, HIV infection, malignancy, long-term steroid use, chronic renal failure, liver cirrhosis, decreased immune function, and septicemia. 5, 22 Initial workup involves laboratory evaluation. White blood cell (WBC) count typically ranges from 4 to 23 thousand with an average at 11.8 thousand, just above the 10-to 11-thousand upper limit of normal. Elevated erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) are nearly always present, with sensitivities reaching up to 90%, albeit not specific for infection. 5 The rule of 50% has been coined: 50% of patients are older than 50 years of age; symptoms last more than 3 months in 50%; fever is present in 50%; WBC count is normal in 50%; genitourinary tract is the primary source in 50%; Staphylococcus aureus is causative microbe in more than 50%; lumbar spine involvement is present in 50%; and no primary site is detected in 50%. 23 Numerous imaging modalities may assist in the evaluation for vertebral osteomyelitis including radiography, nuclear medicine imaging, and MRI. Radiography may reveal late osseous destruction, but in an earlier stage of the disease, findings may resemble those of common degenerative processes, or findings may be completely absent. In WBC scans, demonstrate increased avidity with osteomyelitis; however, like ESR and CRP laboratory values, high sensitivities exist but specificity is low and therefore wide differentials remain. 5 Alternatively, the sensitivity of MRI for vertebral osteomyelitis is often reported between 76% and 100% (mean 91%), with a corresponding specificity ranging from 65% to 96% (mean 82%). 19 Furthermore, signal changes identified by MRI can be seen in early stages of the infection, and therefore MRI serves as the gold standard in imaging modalities.
Nevertheless, practice currently recommends the procurement of histological and microbiological samples in the confirmation and identification of specific organisms, thereby allowing appropriate treatment targeted to a specific microorganism. Obtaining a surgical sample will always be a viable option for confirming the diagnosis. Yet percutaneous biopsy with fluoroscopic or CT guidance has been proven as a viable, faster, and more cost-effective approach that is associated with fewer complications. 17, 24 The first percutaneous vertebral bone biopsy was described by Ball in 1934. 1 The utilization of image guidance was first seen with radiography in 1949, fluoroscopy in 1969, CT in 1981, MRI in 1986, and CT fluoroscopy in 1996.
24
A review of the literature has suggested a wide range in the success rates for percutaneous biopsy. Many studies from the 1990s and early 2000s reported the accuracy of a percutaneous biopsy of vertebral lesions with CT or fluoroscopy guidance ranging from 88% to 100%. 24 A recent retrospective review by Sehn and Gilula of 113 cases in which percutaneous biopsy was used for the diagnosis and identification of causative organisms poses a contrast to the results from the 1990s and 2000s, with a positive histological result found in 63 (55.7%) of 113 cases and a positive microbiological result found in only 28 (30.4%) of 92 cases. 22 The musculoskeletal radiologists at University Hospitals Case Medical Center shared a similar suspicion for the low yield of image-guided percutaneous biopsy in cases of vertebral osteomyelitis.
Methods
A retrospective case review was performed of all patients who underwent a CT-guided percutaneous bone biopsy for vertebral osteomyelitis over an approximately 9-year period, specifically between January 2005 and October 2013. All procedures were performed at University Hospitals Case Medical Center in Cleveland, Ohio, which serves as a Level II academic center. Initial approval for the retrospective review was obtained from the institutional review board. Each intervention had already been performed, so no patients were placed at any additional risk. Furthermore, no financial incentive was given to any of the patients. Upon receiving institutional review board approval, a retrospective review of the institution's radiology PACS system was performed by searching the procedure code used to bill for percutaneous bone biopsy, which yielded over 600 results. The list was filtered to include only those patients who had received a vertebral bone biopsy summing a total of 213 procedures on 209 patients.
These 213 vertebral bone biopsies were categorized according to the ordering clinician's level of suspicion for osteomyelitis and the indication listed on the radiology intervention requisition. The study excluded a subset of 116 patients, the majority of whom had known malignancy, and the primary purpose of the study was to investigate for the presence of metastases. A smaller group of 13 cases was used to investigate for any etiology, with the range in order of decreasing level of suspicion including infection or neoplasm, degenerative changes, and inflammatory processes. This study focuses on a cohort of 84 patients. Of these, 4 patients had procedures performed on 2 separate occasions: 2 of the procedures were for a suspected neoplasm and 2 were for suspected osteomyelitis. For the 2 patients who had procedures performed twice for osteomyelitis, multiple months elapsed before a recurrence of symptoms warranting the second biopsy.
The primary clinician first indicated whether there was a strong clinical suspicion for vertebral osteomyelitis, taking into consideration advanced imaging findings in correlation with the patient's history and laboratory values. However, the musculoskeletal radiologist made the final decision regarding whether the entire picture fit that of vertebral osteomyelitis and whether to perform the percutaneous biopsy.
Our institution does not have a standardized method to include or exclude patients from having the procedure. However, the musculoskeletal radiologists required that all patients have some form of advanced imaging suggesting an infectious process prior to the procedure. Of the 84 patients who underwent the procedure, 80 (95.2%) underwent immediate pre-biopsy advanced imaging. Of these 80 patients, 78 (97.5%) had pre-biopsy MRI studies that raised concern for osteomyelitis/discitis. In the vast majority of these MRI-suspicious cases, the radiologists were confident in the diagnosis of osteomyelitis/discitis and/or periligamentous fluid collection concerning for infection without proposing a differential diagnosis. This study did not focus on statistically comparing the MRI reports. For the remaining 2 of 80 patients who underwent advanced imaging other than MRI, CT was performed and followed by nuclear medicine imaging including PET in 1 case, and bone scanning and WBC scanning in the second case. In both patients, the pre-biopsy nuclear imaging raised concern for an inflammatory or infectious process (Figs. 1-3) .
For the 4 patients without imaging prior to the biopsy, 2 were from satellite hospitals and information could not be collected during the chart review. One of the patients had numerous prior lumbar surgeries and complications; although information was not present to explain why prebiopsy advanced imaging was not performed, the screening CT performed on the day of the biopsy detected a periligamentous fluid collection, which was aspirated. For the last case without advancing imaging prior to the biopsy, the patient had known chronic osteomyelitis and is one of the two patients mentioned earlier in the paper who had a percutaneous biopsy for vertebral osteomyelitis performed on 2 separate hospital visits. For this patient, MRI had been performed prior to the first biopsy, and the second biopsy was performed in the same location as seen on this MR image. Therefore, when taking these limitations into consideration, including incomplete charting in the electronic medical records, and also taking into consideration the patient's history and advanced imaging, 84 (100%) of the 84 patients had advanced imaging prior to the biopsy.
Biopsy was performed in all cases under CT guidance. Complete blood count, prothrombin time, and international normalized ratio were obtained prior to the procedure. A preprocedural 1-to 2-mm thin-slice CT scan covering the area of interest was acquired, and, based on the results, the approach and site of skin puncture were determined. The biopsy was performed with the patient under conscious sedation or, in selected cases of comorbidities or inability of the patient to lie prone, under general anesthesia. Local anesthesia was also used, and the procedure was performed under sterile conditions.
Biopsy was performed using either a Laurane bone biopsy system (Laurane Medical) or a Bonopty bone biopsy system (Radi Medical Systems). The Laurane system consists of an 11-gauge external cannula with an internal stylet and a 12.5-gauge trephine biopsy needle. The Bonopty system consists of 14-gauge external cannula and internal drill and a 16-gauge trephine biopsy needle. In both systems the external cannula and stylet/drill were inserted into the bone and then the internal stylet/drill was replaced by the trephine biopsy cutting needle, and the biopsy was performed. In the lumbar spine the approach was transpedicular, whereas in the thoracic spine it was transpedicular or intercostovertebral. The patients' vital signs were monitored throughout the procedure.
In general, our radiologist attempted to attain an aspiration of the disc and an adequate core sample from the vertebral endplate disc complex. When focal fluid collections were visualized, the procedure specifically targeted and aspirated these collections. If permitted, multiple core biopsy samples were collected. Often a satisfactory single core biopsy would be cut in half to be sent to both microbiology and pathology.
Our radiologists' primary goal was to gather a sufficient sample for microbiology and their secondary goal was to gather a sample for surgical pathology. Often when only a small or single sample was obtained, all of it was sent only to microbiology. The radiologist used clinical judgment during each individual procedure to determine whether a single or additional core biopsy should even be performed. For example, if it appeared that sufficient purulent fluid had been collected from a phlegmon or abscess, a core biopsy might have to be avoided to prevent further discomfort to the patient. In certain cases, patients could not tolerate further biopsy and this stopped the procedure.
Results
All samples were sent to the lab for bacterial Gram stain, culture, fungal culture, and mycobacterial culture. Samples were sent to pathology for histological evaluation in 61 of 84 cases.
At least 1 core sample was obtained in 74 of the 84 patients (88.1%). Of the 10 patients in whom a core biopsy could not be performed, the procedural dictations specifically mentioned the aspiration of a sizeable fluid collection in 6 the patients and reportedly measuring up to 20 ml. Three reports did not specify why a core biopsy was not collected, but in reiteration, the radiologist used clinical judgment on a case-by-case basis to determine how much sample was needed. One of the patients could not tolerate the procedure further, and therefore the procedure was aborted without a core sample being obtained. On a few occasions, patients could not tolerate the initial aspect of the procedure and the patient had to be brought back at a different time, often requiring full sedation.
Histology was positive in 25 of the 61 samples collected, yielding a proportion of positive histology per total number of biopsies for osteomyelitis/discitis of 41.0%. Microbiology was less predictive with only 16 of the 84 samples collected (19.0%) yielding results. In 44 of the 84 total samples (52.4%), the patients were not treated with antibiotics prior to the procedure. Of these 44 patients, 9 had positive samples, yielding a 20.5% (9/44) accuracy rate. Forty of the 84 patients (47.6%) were treated with antibiotics prior to the procedure. Of these 40, 7 had positive samples, yielding 17.5% (7/40) accuracy rate. Using chi-square analysis to compare the expected microbiology results of those patients not having been treated with antibiotics prior to the biopsy with the observed results from patients having been treated prophylactically, the 1-tailed p value was 0.4748 (> 0.05). Therefore, the difference in results between those not treated before biopsy and those treated prophylactically was not statistically significant. Table 1 shows the yield of histology and microbiology based on the total number of cases collected when there was a clinical suspicion of vertebral osteomyelitis, and Table 2 shows the yield of microbiology according to the presence or absence of prophylactic antibiotic administration.
The majority of the biopsies were performed at the thoracic and lumbosacral levels, 37 and 46 cases, respectively, with only 1 cervical biopsy. Eleven of the 37 thoracic biopsies (29.7%) were positive, whereas only 5 of the 46 within the lumbosacral region (10.9%) and 0 of the 1 cervical case were positive. Eight of the 16 positive biopsy cultures (50%) were of S. aureus. The remaining microorganisms are as follows: coagulase-negative Staphylococcus (n = 3), Escherichia coli, Enterococcus faecium, Proteus mirabilis, Candida, and only Mycobacterium tuberculosis (n = 1 for each).
The yield of microbiology according to vertebral body level is shown in Table 3 .
Ten patients had positive blood and/or urine cultures. Of these, 8 of the 10 positive systemic cultures (80%) demonstrated the same pathogen identified by percutaneous biopsy. The 2 cases of systemic infection without positive biopsy cultures were of S. aureus and coagulase-negative Staphylococcus. The high frequency of these pathogens suggests false negatives of the biopsy samples. Therefore, in 8 of 16 cases of positive microbiology established by percutaneous biopsy, the pathogens were also identified by positive blood or urine cultures. After factoring out the 8 cases in which the systemic culture provided the same results as the biopsy, only 8, or half, of the 16 positive biopsy cultures provided additional information to the clinician concerning the pathological microbe present and how treatment might need to be adjusted. Only 8 of the 84 total biopsies with an initial high suspicion for osteomyelitis (9.5%) provided additional information to the clinician concerning the pathological microbe present and how treatment might need to be adjusted. On the other hand, 89 of the 116 samples (76.7%) collected with the primary concern of neoplasm yielded a diagnosis. Limitations to this study must be acknowledged. Although each of the procedures was performed at the same institution by 3 board-certified musculoskeletal radiologists, varying intraprocedural circumstances prevented the acquisition of the exact same sample in each case. As mentioned earlier, each radiologist used clinical judgment during each individual procedure to determine whether a single or additional core biopsy should even be performed. For example, if it appeared that sufficient purulent fluid had been collected from a phlegmon or abscess, a core biopsy may have been avoided to prevent further distress to the patient. In certain cases patients could not tolerate further biopsy, stopping the procedure. As a result, only 68 pathology samples were collected from the 84 patients who had undergone the procedure. In addition, there was variability regarding sample type and size sent for microbiology analysis. Furthermore, the analysis of the data may have differed among the pathologists.
To collect the largest patient population for our study, the time frame of nearly 9 years meant that period dates back to 2005 when the institution first began utilizing PACS. Patients who had undergone an image-guided percutaneous vertebral biopsy may have been unaccounted for, although we considered this would represent only a small number of cases, if in fact any cases were actually missed. Furthermore, the institution transitioned from paper documents to electronic medical records in the early 2000s. It is not entirely impossible that data may have been lost during this transition.
To detail the follow-up and treatment of each patients is beyond the scope of this study. The study is based on the suspicion of vertebral osteomyelitis, and definitive osteomyelitis is not always known. A cursory review of discharge summaries for the 84 patients who underwent a vertebral biopsies for osteomyelitis indicated that 71 (84.5%) were discharged on antibiotics. In the majority of these cases, the patients were on long-term antibiotics for osteomyelitis/discitis; however, it is beyond the scope of this study to perform a statistical analysis of which patients were treated specifically for vertebral osteomyelitis/discitis (or, alternatively, for example, sepsis), the length of treatment (and whether the length corresponded to what is recommended for the treatment of vertebral osteomyelitis/discitis), which type of antibiotics were used, whether the patients improved clinically, and so on.
Of the 13 patients for whom discharge paperwork did not specifically mention subsequent antibiotic treatment, 6 discharge summaries were not identified which is due to paperwork located at our satellite institutions or to limitations with electronic medical records as mentioned above. Only 7 discharge summaries (or follow-up outpatient notes) specifically mentioned the cessation of antibiotic use due to negative biopsy results, with only 1 case attributing the patient's back pain to metastasis (which did not correspond to our biopsy results). In effect, taking into consideration that there were only 7 post-biopsy reports specifically excluding an infectious process, 77 of 84 patients, or 91.7%, continued to be treated with antibiotics after discharge.
Discussion
Although the correlation of clinical presentation and MRI imaging provides up to 100% sensitivity and specificity for vertebral osteomyelitis, 19 biopsy remains the gold standard in diagnosis. Isolation of the causative organism is considered optimal to tailor appropriate antibiotic treatment. 9 Mycobacterium tuberculosis is one of the most common infectious pathogens worldwide, albeit less prevalent in the West. It is also known to afflict the vertebral bodies, serving as the most common pathogen extracted from vertebral biopsy samples. 5, 7, 15, 17 It typically presents with a subacute clinical course. Magnetic resonance imaging demonstrates characteristic "skip lesions" in which contiguous vertebral bodies are affected without involvement of the intervertebral discs. The pathogen is notoriously difficult to culture, typically requiring 6-8 weeks for the isolation, 7, 21 although now it can be done faster using polymerase chain reaction.
In the United States, gram-positive cocci are the most common culprit microorganisms of discitis/osteomyelitis, specifically S. aureus and to a lesser degree Streptococ- cus. 4, 13, 21 In a review of the literature, Cheung and Luk reported Staphylococcus and Streptococcus for more than 50% of vertebral osteomyelitis cases. 5 Our results confirm this finding with 8 of 16 positive samples yielding Staphylococcus on culture. Escherichia coli is often seen with concurrent urinary tract infections, as seen in 1 patient in our study. Other correlations include gramnegative bacilli in intravenous drug abusers or coagulasenegative Staphylococcus and Streptococcus viridans in the immunocompromised. 5 Even though much less common, physicians must take into account the possibility of fungal infections, which typically present as a result of Candidemia with the delayed complication of spondylodiscitis several months later. 16 Rankine and colleagues stressed the importance of attaining fungal cultures in that Candida was isolated in 1 patient after treatment with flucloxacillin. 21 Our study also supports this finding, with 1 of 16 positive samples yielding Candida.
Endoscopic biopsies provide an approximately 90% yield for vertebral osteomyelitis. 26 However, it is well known that percutaneous intervention is safer and provides quicker results at a lower cost and with decreased morbidity. 17, 24 As mentioned in the introduction, percutaneous vertebral biopsies were described as early as 1934 by Ball, and image guidance was subsequently added in 1949. 1, 24 Computed tomography scanning is currently held to be the modality of choice for guidance by the majority of authors, although some authors, such as Kim et al. in 2013, have demonstrated equal success using fluoroscopy.
17
Many retrospective studies and reviews have suggested a high success rate using percutaneous biopsy for vertebral lesions. In 2001, Chew and Kline 6 performed a retrospective evaluation of spontaneous (non-postoperative) infectious discitis involving 105 biopsies in 92 patients, reporting a 97.1% success rate. In a 2007 review of percutaneous biopsy methods used in the spine, Tehranzadeh et al. referenced 8 articles with an accuracy rate approaching 88%-100%. 24 In a 2009 article entitled "CTguided fine-needle aspiration in vertebral osteomyelitis: true usefulness of a common practice," de Lucas et al. acknowledged 13 reports with accuracy results ranging from 71%-100%. However, the paper clearly acknowledged that "these series usually mix many cases of neoplastic vertebrae and a minor portion of spinal infections. In addition, these series frequently described a relatively lower sensitivity in the subgroup of inflammatory cases rather than tumor cases." 10 It is already known that the role of image-guided biopsy in diagnosing malignant conditions is well established-89 of 116 samples (76.7%) collected in our trial when there was an initial concern for neoplastic process were diagnostic-but its role in diagnosing infectious diseases is less accurate.
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It is therefore imperative to scrutinize how statistics are calculated and delineate findings according to neoplastic and nonneoplastic etiologies. Chew and Kline 6 acknowledged that their high 91% diagnostic rate was based on the 39 samples with microorganisms identified out of 43 cases in which "active disc space infection" was present. "A patient without positive results from microbiology was considered not to have active disk space infection. The strict criteria for the presence of active disk space infection used for the purposes of this retrospective study are not necessarily the criteria that one might use in the clinical setting to guide patient care" (emphasis added). Following up their reference to the 8 articles with diagnostic results ranging between 88% and 100%, Tehranzadeh and colleagues acknowledged that the ability to culture from an infection is poor, specifically referencing 4 articles in which the accuracy rate ranged from 46% to 91% (the 91% accuracy rate was from the Chew and Kline article discussed above). 24 Meticulous evaluation of the statistics pertaining to the success rate of percutaneous biopsy in identifying vertebral osteomyelitis from large, general studies of vertebral lesions indicates that the success rates are lower. Early in 1998 Kornblum et al. evaluated CT-guided biopsy of the spine in 103 patients, in whom 90 adequate samples were obtained; 67 of the 90 samples were diagnostic; and 18 infections were identified based on cytological and/or pathological results, with 10 of 17 cases (58.8%), yielding positive bacterial cultures. However, there appears to be overlap in the data and 19 cases of "normal tissue" are mentioned without any suggestion of false negatives. 18 Enoch et al. reviewed 98 CT-guided procedures in 103 patients; only 9 of 25 samples (36%) were positive for cultures. 11 In a 2013 retrospective study of image-guided biopsy, Kim et al. reported a 97.1% overall success rate. They later claimed a 78.8% success rate (134/170) in the diagnosis of infection; however, this statistic is based on the diagnosis of infection by histology or clinical outcome. In only 51/134 cases were causative organisms identified (38.1%).
17
There have been more and more studies recently focusing solely on biopsy for osteomyelitis and spondylodiscitis. As early as 1992, Fouquet et al. reviewed data obtained in 25 patients with discitis after lumbar surgery; of these, only in 9 cases were microorganisms identified (36%). 12 Hadjipavlou et al. in 2003 examined osteometabolic disorders in 68 patients, in whom a total of 71 biopsy samples were obtained and in whom a microbial diagnosis was established in 30 (44%). 15 Colmenero and associates 7, 8 evaluated specifically for tuberculous osteomyelitis; in 2004, 7 they compared open to percutaneous biopsies and found 61.7% and 48% of samples to be positive, respectively. 7 Yang and coworkers compared endoscopic and percutaneous techniques for biopsy and reported a positive result in 90% (18/20 patients) using endoscopic biopsy and in 47% (15/32 patients) using percutaneous biopsy. 26 Ballah et al. recently examined osteomyelitis in children and found 12 of the 26 cases to be positive (46%). 2 The largest and most comprehensive was a report by Sehn and Gilula who indicated that 63 of 113 cases were positive when samples were examined histologically (55.7%) and only 28 of the 92 cases positive when samples were examined microbiologically (30.4%). 22 Our current large study confirms the low yield from image-guided percutaneous biopsy when there is a high clinical suspicion of vertebral osteomyelitis; we observed positive histological results in only 38.2% (26/84) and positive microbiological results in 19.0% (16/84) . In addition, of the 16 cases positive for microorganisms from biopsy, 8 cases, or 50%, were also positive for blood cul-tures and urine cultures. Therefore, percutaneous biopsy for osteomyelitis helped to identify unknown microbes only in 8 (9.5%) of 84 total cases. It is important to take note of Patzakis and colleagues' 1991 analysis of 61 patients with suspected osteomyelitis, in which 11 of 13 microbes (85%) isolated from blood cultures corresponded to biopsy specimens, 20 confirming a high correlation of systemic cultures for vertebral osteomyelitis.
Initially it was felt that biopsy should be performed only when a microoganism other than Staphylococcus was suspected or in situations in which there did not appear to be clinical evidence of improvement or normalization of laboratory findings after high-dose treatment.
14 Authors such as Haaker et al. in 1997 recommended the immediate commencement of empirical antibiotic treatment when clinicians will later be able to narrow antibiotic coverage to the specific microbe discovered. 14 However, it has now become routinely recommended that antimicrobial treatment not be started until after a biopsy sample is obtained except in cases of sepsis or neutropenia. (6/12) prior to the use of antibiotics and in only 25% (2/8) after antibiotic initiation; Grados, in 80% of those not treated with antibiotics but only in 48% of those treated with antibiotics; and de Lucas, in 60% before and only 23% after antibiotic treatment. 10, 13, 21 However, our comparison of the expected microbiology results from those patients who did not receive antibiotics prior to the percutaneous biopsy (9/44 or 20.5%) with the observed results from patients who received antibiotics prophylactically (7/40 or 17.5%) indicated that the results were similar for both groups and that the difference was not statistically significant (p = 0.4748). In other words, the proportion of positive cultures to those biopsied was low for both patients receiving and not receiving antibiotics prior to the biopsy, a finding in contrast to what has been previously reported. It is important to note that our study only obtained 16 positive microbiology results from the percutaneous biopsy; an analysis of a larger patient pool with a greater number of positive microbiology may demonstrate statistical significance and support the current guidelines to hold off prophylactic antibiotic treatment while awaiting culture results.
Conclusions
In summary, our department's extremely low yield of microorganisms recovered (16/84 or 19.0%) from CTguided percutaneous biopsy confirms the findings seen in the study performed by Sehn and Gilula in 2012 in which positive microbiology was demonstrated in only 28 of 92 cases (30.4%). 22 Additionally, the data from the present study indicate that in only a smaller subset of patients (8/84 or 9.5%) did the biopsy results provide clinicians with additional information as to specific microorganisms present and how treatment might need to be adjusted in light of these pathogens.
Image-guided percutaneous biopsy for suspected vertebral osteomyelitis is less likely to impact patient management than previously thought. Our data also suggest that prebiopsy antibiotic therapy does not significantly affect the pathogen recovery rate. A prospective trial is necessary to confirm these findings and determine whether any modifications to the current guidelines ought to be made. Until then, clinicians managing patients with suspected osteomyelitis should consider the results from this study when determining which patients should undergo image-guided biopsy. Patients in whom there are no clinical or imaging findings suspicious for atypical pathogens may be better managed with a course of empirical antibiotic therapy and without undergoing percutaneous intervention.
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